Actively Recruiting

Age: 18Years - 100Years
All Genders
Healthy Volunteers
NCT06338696

Thailand ATTR-CM Registry

Led by Mahidol University · Updated on 2025-05-08

105

Participants Needed

8

Research Sites

308 weeks

Total Duration

On this page

Sponsors

M

Mahidol University

Lead Sponsor

P

Pfizer

Collaborating Sponsor

AI-Summary

What this Trial Is About

The investigators of this registry aim to study the natural history, clinical presentation, characteristics, and imaging findings of patients diagnosed with ATTR amyloidosis in Thailand longitudinally. This will enable the investigators to study this disease in depth. With a better understanding, the investigators can aim to develop early screening programs for at-risk patients, raising awareness among non-cardiologists. As amyloid-specific therapies have now become available in Thailand, the findings of this registry can be helpful for epidemiological studies in Thailand.

CONDITIONS

Official Title

Thailand ATTR-CM Registry

Who Can Participate

Age: 18Years - 100Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Age over 18 years
  • Diagnosis of Transthyretin Amyloid Cardiomyopathy (ATTR-CM), symptomatic or asymptomatic
  • Evidence of cardiac involvement by echocardiogram showing left ventricle wall thickness of 12 mm or more
  • One or more of the following:
    • Positive scintigraphy with 99mTC-DPD, 99mTC-PYP, or 99mTC-HMDP showing Perugini grade 2 or higher and/or heart to contralateral lung ratio over 1.5
    • Positive scintigraphy with Perugini grade 1 plus positive cardiac biopsy with Congo red stain in 4 or more sites
    • Positive scintigraphy with Perugini grade 1 plus positive non-cardiac biopsy with Congo red stain
    • Abnormal cardiac MRI with subendocardium late gadolinium enhancement and/or elevated native T1 value and/or increased extracellular volume over 0.4 plus positive cardiac or non-cardiac biopsy with Congo red stain
Not Eligible

You will not qualify if you...

  • Amyloidosis caused by proteins other than transthyretin, such as light chain amyloidosis
  • Secondary amyloidosis diagnosis

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 8 locations

1

Faculty of Medicine at Chulalongkorn University

Bangkok, Thailand

Not Yet Recruiting

2

Faculty of Medicine Ramathibodi hospital, Mahidol University

Bangkok, Thailand

Not Yet Recruiting

3

Faculty of Medicine Siriraj Hospital, Mahidol University

Bangkok, Thailand

Not Yet Recruiting

4

Phramongkutklao Hospital

Bangkok, Thailand

Not Yet Recruiting

5

Faculty of Medicine Chiang Mai University

Chiang Mai, Thailand

Not Yet Recruiting

6

Queen Sirikit Heart Center of The Northeast

Khon Kaen, Thailand

Not Yet Recruiting

7

Faculty of Medicine, Thammasat University

Pathum Thani, Thailand

Not Yet Recruiting

8

Prince of Songkla University

Songkhla, Thailand

Actively Recruiting

Loading map...

Research Team

K

Kanchalaporn Jirataiporn, B.N.S.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Thailand ATTR-CM Registry | DecenTrialz